OAN’s James Meyers
9:06 AM – Thursday, June 13, 2024
The Supreme Court on Thursday unanimously rejected a challenge to the abortion pill mifepristone, meaning the abortion pill can remain on the market.
Advertisement
In a 9 to 0 ruling authored by Justice Brett Kavanuagh, the high court concluded the group of pro-life doctors that brought the case forward lacked standing to challenge the Food and Drug Administration’s (FDA) prior regulatory approval of the pill.
“Those standing allegations suffer from the same problem—a lack of causation. The causal link between FDA’s regulatory actions and those alleged injuries is too speculative or otherwise too attenuated to establish standing,” Kavanaugh wrote in his opinion.
With the court’s decision, it avoided reaching a decision on the legal…
